Assignee
ANTHERA PHARMACEUTICALS INC
US·1 granted patent·1 pending application·2 citations·filing 2008–2017
Top patents by PatentIndex Score
2 records- 0166US8048880B2Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapiesANTHERA PHARMACEUTICALS INC·Filed 2008·Granted Nov 1, 2011·2 cites·30 claims
- 0226US2017369551A1METHODS OF TREATING IgA NEPHROPATHY AND HENOCH-SCHONLEIN PURPURA NEPHRITIS USING A B-CELL ACTIVATING FACTOR (BAFF) INHIBITORANTHERA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ANTHERA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →